Personalis
Amanda Castle has extensive work experience in the biopharmaceutical industry. Amanda'smost recent position was as the Director of Biopharma Business Development - Europe at Personalis, Inc., where they represented NeXT Personal®, a highly advanced liquid biopsy assay. Prior to this, Amanda held various roles at TwinStrand Biosciences, including Director of Biopharma and Strategic Accounts and Senior Commercial Development Manager - Europe. Amanda also worked at Ovation.io as the Head of Strategic Alliances and as a Business Development Executive. Amanda's earlier career includes positions at Metabolon, Inc. as a Business Development Executive, at QIAGEN as a Clinical Account Executive, and at Illumina as an Executive Clinical Sequencing Specialist. Amanda also has experience at Roche Applied Science, Invitrogen, Bayer Crop Science, and GSK in various sales, technical, and molecular biology roles.
Amanda Castle attended Anglia Ruskin University from 1994 to 2000. During this time, they obtained a Bachelor's degree in Cell/Cellular and Molecular Biology.
This person is not in any offices
Personalis
4 followers
Personalis is a leader in population sequencing and cancer genomics, with a focus on data, scale, efficiency and quality. Personalis operates one of the largest sequencing operations globally and is currently the sole sequencing provider to the VA Million Veteran Program (MVP). In oncology, Personalis is transforming the development of next-generation therapies by providing more comprehensive molecular data about each patient’s cancer and immune response. The Personalis® ImmunoID NeXT Platform® is designed to adapt to the complex and evolving understanding of cancer, providing its biopharmaceutical customers with information on all of the approximately 20,000 human genes, together with the immune system, from a single tissue sample. The Personalis Clinical Laboratory is GxP-aligned as well as CLIA’88-certified and CAP-accredited.